Filter Results:
(330)
Show Results For
- All HBS Web
(439)
- People (2)
- News (62)
- Research (330)
- Multimedia (3)
- Faculty Publications (266)
Show Results For
- All HBS Web
(439)
- People (2)
- News (62)
- Research (330)
- Multimedia (3)
- Faculty Publications (266)
←
Page 17 of 330
Results
Sort by
- 06 Dec 2011
- First Look
First Look: Dec. 6
Sahlman, Joseph B. Lassiter, and Liz KindHarvard Business School Case 812-049 In the three years since Bishop and Button purchased Verengo in a leveraged buyout (LBO), the company had gone through dramatic changes. Initially a residential... View Details
Keywords: Sean Silverthorne
- 20 Jan 2015
- First Look
First Look: January 20
Michelle Dipp, MD, Ph.D, CEO and co-founder of OvaScience, had just received a buyout offer from PG Ventures, a private equity firm interested in acquiring the innovative fertility treatments company. The company's first promising... View Details
Keywords: Sean Silverthorne
- 14 Jun 2004
- Research & Ideas
The Big Money for Big Projects
capital structure, board of directors, compensation schemes, etc.—which may or may not be appropriate for any particular asset, the firm can create an entirely different governance system that is ideally suited for the asset in question. Much the same way leveraged... View Details
- 06 Feb 2007
- First Look
First Look: February 6, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=806092 Endo Pharmaceuticals (A): From LBO to...? Harvard Business School Case 806-064 Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck.... View Details
Keywords: Martha Lagace
- ←
- 17